# Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study

> **NCT05161585** · NA · UNKNOWN · sponsor: **Fudan University** · enrollment: 316 (estimated)

## Conditions studied

- Stage III Colorectal Cancer
- Circulating Tumor DNA

## Interventions

- **DIAGNOSTIC_TEST:** ctDNA dynamic monitoring

## Key facts

- **NCT ID:** NCT05161585
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2022-09
- **Final completion:** 2024-09
- **Target enrollment:** 316 (ESTIMATED)
- **Last updated:** 2021-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161585, "Evaluation of Circulating Tumor DNA Guided Surveillance Strategy of Stage III Colorectal Cancer: an Open, Prospective, Randomized Controlled Cohort Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05161585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*